{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T23:52:04Z","timestamp":1693698724842},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T00:00:00Z","timestamp":1512432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s12928-017-0504-7","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T16:49:44Z","timestamp":1512492584000},"page":"1-8","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pathology of stent implantation in internal mammary artery"],"prefix":"10.1007","volume":"34","author":[{"given":"Hiroyoshi","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Braumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Torii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Jinnouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuel","family":"Harari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kutys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloke","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,5]]},"reference":[{"issue":"23","key":"504_CR1","first-page":"e652","volume":"124","author":"LD Hillis","year":"2011","unstructured":"Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(23):e652\u2013735.","journal-title":"Circulation"},{"issue":"17","key":"504_CR2","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1161\/01.CIR.0000127570.20508.5C","volume":"109","author":"UN Khot","year":"2004","unstructured":"Khot UN, Friedman DT, Pettersson G, Smedira NG, Li J, Ellis SG. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation. 2004;109(17):2086\u201391.","journal-title":"Circulation"},{"issue":"11","key":"504_CR3","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.jacc.2004.08.064","volume":"44","author":"S Goldman","year":"2004","unstructured":"Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44(11):2149\u201356.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"504_CR4","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/ejcts\/ezt137","volume":"44","author":"PY Etienne","year":"2013","unstructured":"Etienne PY, D\u2019hoore W, Papadatos S, Mairy Y, El Khoury G, Noirhomme P, et al. Five-year follow-up of drug-eluting stents implantation vs minimally invasive direct coronary artery bypass for left anterior descending artery disease: a propensity score analysis. Eur J Cardiothorac Surg. 2013;44(5):884\u201390.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"504_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJM199607253350401","volume":"335","author":"The Bypass Angioplasty Revascularization Investigation (BARI) Investigators","year":"1996","unstructured":"The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335(4):217\u201325.","journal-title":"N Engl J Med"},{"issue":"10","key":"504_CR6","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1056\/NEJMoa0804626","volume":"360","author":"PW Serruys","year":"2009","unstructured":"Serruys PW, Morice M-C, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961\u201372.","journal-title":"N Engl J Med"},{"issue":"22","key":"504_CR7","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.115.021168","volume":"133","author":"S Bangalore","year":"2016","unstructured":"Bangalore S, Guo Y, Samadashvili Z, Blecker S, Hannan EL. Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction: everolimus-eluting stents versus coronary artery bypass graft surgery. Circulation. 2016;133(22):2132\u201340.","journal-title":"Circulation"},{"issue":"2","key":"504_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrcardio.2015.164","volume":"13","author":"K Yahagi","year":"2016","unstructured":"Yahagi K, Kolodgie FD, Otsuka F, Finn AV, Davis HR, Joner M, et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol. 2016;13(2):79\u201398 (Nature Publishing Group).","journal-title":"Nat Rev Cardiol"},{"issue":"21","key":"504_CR9","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.jacc.2009.05.075","volume":"54","author":"G Nakazawa","year":"2009","unstructured":"Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, et al. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol. 2009;54(21):1924\u201331.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"504_CR10","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.jcin.2016.09.016","volume":"9","author":"C Lutter","year":"2016","unstructured":"Lutter C, Mori H, Yahagi K, Ladich E, Joner M, Kutys R, et al. Histopathological differential diagnosis of\u00a0optical coherence tomographic image interpretation after stenting. JACC Cardiovasc Interv. 2016;9(24):2511\u201323.","journal-title":"JACC Cardiovasc Interv"},{"issue":"32","key":"504_CR11","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","volume":"36","author":"F Otsuka","year":"2015","unstructured":"Otsuka F, Byrne RA, Yahagi K, Mori H, Ladich E, Fowler DR, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015;36(32):2147\u201359.","journal-title":"Eur Heart J"},{"issue":"4","key":"504_CR12","first-page":"519","volume":"2","author":"F Otsuka","year":"2013","unstructured":"Otsuka F, Yahagi K, Sakakura K, Virmani R. Why is the mammary artery so special and what protects it from atherosclerosis? Ann Cardiothorac Surg. 2013;2(4):519\u201326.","journal-title":"Ann Cardiothorac Surg"},{"issue":"3","key":"504_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.athoracsur.2011.04.063","volume":"92","author":"G-W He","year":"2011","unstructured":"He G-W, Fan L, Grove KL, Furnary A, Yang Q. Expression and function of endothelial nitric oxide synthase messenger RNA and protein are higher in internal mammary than in radial arteries. Ann Thorac Surg. 2011;92(3):845\u201350.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"504_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.115.015549","volume":"133","author":"RE Harskamp","year":"2016","unstructured":"Harskamp RE, Alexander JH, Ferguson TB, Hager R, Mack MJ, Englum B, et al. Frequency and predictors of internal mammary artery graft failure and subsequent clinical outcomes: insights from the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial. Circulation. 2016;133(2):131\u20138.","journal-title":"Circulation"},{"issue":"222","key":"504_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijcard.2016.07.052","volume":"11","author":"Y Shiono","year":"2016","unstructured":"Shiono Y, Kubo T, Honda K, Katayama Y, Aoki H, Satogami K, et al. Impact of functional focal versus diffuse coronary artery disease on bypass graft patency. Int J Cardiol. 2016;11(222):16\u201321.","journal-title":"Int J Cardiol"},{"issue":"17","key":"504_CR16","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.jacc.2014.06.1207","volume":"64","author":"V Aggarwal","year":"2014","unstructured":"Aggarwal V, Stanislawski MA, Maddox TM, Nallamothu BK, Grunwald G, Adams JC, et al. Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program. J Am Coll Cardiol. 2014;64(17):1825\u201336.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"504_CR17","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S0735-1097(99)00652-X","volume":"35","author":"L Gruberg","year":"2000","unstructured":"Gruberg L, Dangas G, Mehran R, Hong MK, Waksman R, Mintz GS, et al. Percutaneous revascularization of the internal mammary artery graft: short- and long-term outcomes. J Am Coll Cardiol. 2000;35(4):944\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"504_CR18","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.amjcard.2015.08.040","volume":"116","author":"I Lozano","year":"2015","unstructured":"Lozano I, Serrador A, Lopez-Palop R, Lasa G, Moreu J, Pinar E, et al. Immediate and long-term results of drug-eluting stents in mammary artery grafts. Am J Cardiol. 2015;116(11):1695\u20139.","journal-title":"Am J Cardiol"},{"issue":"6","key":"504_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jcin.2011.12.017","volume":"5","author":"SK Yazdani","year":"2012","unstructured":"Yazdani SK, Farb A, Nakano M, Vorpahl M, Ladich E, Finn AV, et al. Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions. JACC Cardiovasc Interv. 2012;5(6):666\u201374.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12928-017-0504-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-017-0504-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-017-0504-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T19:13:38Z","timestamp":1567883618000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12928-017-0504-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,5]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["504"],"URL":"https:\/\/doi.org\/10.1007\/s12928-017-0504-7","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,5]]},"assertion":[{"value":"19 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was sponsored by CVPath Institute, a non-profit organization dedicated cardiovascular research. There was no industry involvement in the design, conduct, financial support, or analysis of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"CVPath Institute has research Grants from Abbott Vascular, Atrium Medical, Boston Scientific, Biosensors International, Cordis-Johnson&Johnson, Medtronic CardioVascular, OrbusNeich Medical and Terumo Corporation. H. M has received honorarium from Abbott Vascular Japan, Goodman and Terumo Corporation. S. T has received honorarium from Abbott Vascular Japan, Terumo Corporation and SUNRISE lab. R. V has speaking engagements with Merck; receives honoraria from Abbott Vascular, Boston Scientific, Lutonix, Medtronic and Terumo Corporation and is a consultant for 480 Biomedical, Abbott Vascular, Medtronic and W. L. Gore. A. V. Finn has sponsored research agreements with Boston Scientific and Medtronic CardioVascular and is an advisory board member to Medtronic CardioVascular. The other authors report no conflict.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}